Insider · CIK 0001769041
James J. Ferguson III
Files at CVKD (Cadrenal Therapeutics, Inc.). First filing -, latest -.
James J. Ferguson III files SEC Form 4 as officer at CVKD (Cadrenal Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James J. Ferguson III has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | CVKD Cadrenal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +60,000 | $0.00 | $0 | 60,000 | Feb 6, 2025 |
Questions about James J. Ferguson III
Answered from the filings on this page, as of the latest one.
Is James J. Ferguson III buying or selling?
James J. Ferguson III has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James J. Ferguson III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James J. Ferguson III has 0.
Where does James J. Ferguson III file Form 4?
James J. Ferguson III has filed Form 4 at CVKD (Cadrenal Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.